BIOMAT Database Logo BIOMAT Database Logo

[Effect of large doses of pyramidon on glutamic-oxalic transaminase activity in the liver and kidneys]. 1961

I G FAZEKAS, and A G FAZEKAS, and B RENGEI

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D000632 Aminopyrine A pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of AGRANULOCYTOSIS. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of CYTOCHROME P-450 metabolic activity in LIVER FUNCTION TESTS. Amidophenazon,Aminophenazone,Dimethylaminophenazone,Dipyrine,Amidazophen,Amidophen,Amidopyrine,Aminofenazone,Dimethyl-N-aminoantipyrine,Dimethylaminoantipyrine,Eufibron,Dimethyl N aminoantipyrine
D000637 Transaminases A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1. Aminotransferase,Aminotransferases,Transaminase

Related Publications

I G FAZEKAS, and A G FAZEKAS, and B RENGEI
[Activity of glutamic-oxalic and glutamic-pyruvic transaminase in normal newborn infants].
January 1962, Ginekologia polska,
I G FAZEKAS, and A G FAZEKAS, and B RENGEI
[On increase of glutamic-oxalic transaminase (SGPT) activity in myocardial infarction].
October 1961, Polski tygodnik lekarski (Warsaw, Poland : 1960),
I G FAZEKAS, and A G FAZEKAS, and B RENGEI
[Activity of glutamic-oxalic transaminase in patients with active rheumatism].
September 1960, Terapevticheskii arkhiv,
I G FAZEKAS, and A G FAZEKAS, and B RENGEI
[Activity of glutamic-oxalic-acetic transaminase in the erythrocytes and serum in blood diseases. Increase of the activity of glutamic-oxalic-acetic transaminase in the erythrocytes in hemolytic syndromes].
August 1959, Polski tygodnik lekarski (Warsaw, Poland : 1960),
I G FAZEKAS, and A G FAZEKAS, and B RENGEI
Effect of liver damage on serum glutamic oxalacetic transaminase and glutamic pyruvic transaminase.
April 1962, Journal of the Indian Medical Association,
I G FAZEKAS, and A G FAZEKAS, and B RENGEI
Serum glutamic oxaloacetic transaminase activity and serum glutamic pyruvic transaminase activity in liver diseases.
April 1960, Indian journal of medical sciences,
I G FAZEKAS, and A G FAZEKAS, and B RENGEI
[Enzymatic activity of blood platelets. Determination of glutamic oxalic acetic transaminase].
April 1960, Revue francaise d'etudes cliniques et biologiques,
I G FAZEKAS, and A G FAZEKAS, and B RENGEI
The effect of oral ethanol on glutamic pyruvic and glutamic oxalacetic transaminase activity in the rat liver.
March 1958, Quarterly journal of studies on alcohol,
I G FAZEKAS, and A G FAZEKAS, and B RENGEI
[Change of glutamic-oxalic transaminase activity in Botkin's disease and in other conditions. I].
March 1961, Klinicheskaia meditsina,
I G FAZEKAS, and A G FAZEKAS, and B RENGEI
[Changes of glutamic-oxalic transaminase in myocardial infarct and stenocardia].
January 1961, Trudy Leningradskogo sanitarno-gigienicheskogo meditsinskogo instituta,
Copied contents to your clipboard!